21 October 2025

Last updated: Monday 20 October 2025

Research Directory

Oncology Review: 2014 was a record year for approvals

Balance of power in pharmaceuticals is shifting

Highlights of the new EU Clinical Trials Regulation

Collaboration to deliver superior value to patients

A greater patient voice in drug development

The Case for HTA co-operation

Commentary: How are regulators are supporting innovation?

The EU Clinical Trials Regulation: Legislators see light at the end of the tunnel

Debate heats up over access to clinical trial data

The Special Protocol Assessment: Regulatory success is not guaranteed